These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7345340

  • 1. [Cellular immunity in carcinoma of the uterine cervix].
    Pasqualini RS, Giraudo Conesa LC, Chevallier R.
    Medicina (B Aires); 1981; 41 Suppl():155-60. PubMed ID: 7345340
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
    Rivera ES, Hersh EM, Bowen JM, Barnett JW, Wharton T, Murphy SG.
    Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
    [No Abstract] [Full Text] [Related]

  • 4. Cellular immunity as a host response to squamous carcinoma of the cervix.
    Goldstein MS, Shore B, Gusberg SB.
    Am J Obstet Gynecol; 1971 Nov; 111(6):751-5. PubMed ID: 5166388
    [No Abstract] [Full Text] [Related]

  • 5. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
    Wells SA, Melewicz FC, Christiansen C, Ketcham AS.
    Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
    [No Abstract] [Full Text] [Related]

  • 6. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
    Schmeisser G, Kademann J.
    Arch Geschwulstforsch; 1980 May; 50(2):169-72. PubMed ID: 7436701
    [Abstract] [Full Text] [Related]

  • 7. [Immunologic study of a case of spontaneous regression of metastatic carcinoma of the portio].
    Moggian G, Barboni F, Sabetta C.
    Cancro; 1974 May; 27(3):165-8. PubMed ID: 4465036
    [No Abstract] [Full Text] [Related]

  • 8. [Diagnosis of cellular immune reactions against autologous and homologous tumor tissue in cervix cancer patients using the direct leukocyte migration inhibition test].
    Koenig UD.
    Arch Gynecol; 1979 Jul 20; 228(1-4):597-8. PubMed ID: 485496
    [No Abstract] [Full Text] [Related]

  • 9. [In vitro migration of normal leucocytes. The effect of different chemical compounds (author's transl)].
    Giraudo Conesa LC, Astaldi G.
    Sangre (Barc); 1979 Jul 20; 24(1):18-23. PubMed ID: 424971
    [No Abstract] [Full Text] [Related]

  • 10. [Circulating immunocomplexes in the serum of female patients suffering with cancer of the uterine cervix (author's transl)].
    Vodvárka P, Willaschek J, Lochman I, Vrtná L.
    Cesk Gynekol; 1982 May 20; 47(4):272-8. PubMed ID: 7094057
    [No Abstract] [Full Text] [Related]

  • 11. Letter: Cell mediated response to herpes simplex virion and non-virion antigens in patients with cervical carcinoma with a depressed response to phytohemagglutinin.
    Sprecher-Golberger S, Thiry L, de Halleux F, Bossens M, Gould I.
    Biomedicine; 1975 Nov 10; 23(9):399-401. PubMed ID: 182294
    [No Abstract] [Full Text] [Related]

  • 12. Immunological status in cervical cancer in relation to pelvic irradiation.
    Chandra M, Chander S.
    Indian J Med Res; 1986 Oct 10; 84():413-7. PubMed ID: 3781598
    [No Abstract] [Full Text] [Related]

  • 13. Circulatory and cellular immune responses to squamous cell carcinoma of the uterine cervix.
    Chiang WT, Wei PY, Alexander ER.
    Am J Obstet Gynecol; 1976 Sep 01; 126(1):116-21. PubMed ID: 786019
    [Abstract] [Full Text] [Related]

  • 14. Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix.
    Chen SS, Koffler D, Cohen CJ.
    Am J Obstet Gynecol; 1975 Jan 01; 121(1):91-5. PubMed ID: 1115121
    [Abstract] [Full Text] [Related]

  • 15. Types of cell-mediated immune response in invasive zone of carcinoma of the uterine cervix.
    Kozłowski H, Hrabowska M.
    Arch Geschwulstforsch; 1979 Jan 01; 49(3):240-50. PubMed ID: 496564
    [No Abstract] [Full Text] [Related]

  • 16. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
    Micke O, Bruns F, Schäfer U, Prott FJ, Willich N.
    Anticancer Res; 2005 Jan 01; 25(3A):1663-6. PubMed ID: 16033078
    [Abstract] [Full Text] [Related]

  • 17. Characterization of tumor-associated antigen from human carcinoma of the uterine cervix.
    Nadkarni JJ, Satam MN, Damle SR, Rajpal RM, Nadkarni JS.
    Gynecol Oncol; 1982 Apr 01; 13(2):175-83. PubMed ID: 7076034
    [No Abstract] [Full Text] [Related]

  • 18. Cell-mediated immunity in patients with ovarian carcinoma.
    Chen SY, Koffler D, Cohen CJ.
    Am J Obstet Gynecol; 1973 Feb 15; 115(4):467-70. PubMed ID: 4346615
    [No Abstract] [Full Text] [Related]

  • 19. Lymphocyte function and HL-A antigen frequency in gynecologic squamous cancer. A preliminary report.
    Twomey PL, Rogentine GN, Chretien PB.
    Int Surg; 1974 Sep 15; 59(9):468-72. PubMed ID: 4414534
    [No Abstract] [Full Text] [Related]

  • 20. A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years.
    Nedergaard BS, Ladekarl M, Nyengaard JR, Nielsen K.
    Gynecol Oncol; 2008 Jan 15; 108(1):106-11. PubMed ID: 17945335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.